SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FDA Reclassifies Proellex® Clinical Hold Status: Repros Therapeutics Inc. to Proceed With Phase 2 Study of Low Dose Oral Proellex® in the Treatment of Endometriosis